Statin Intensification and LDL Cholesterol Reduction are Associated with Longitudinal Changes in Circulating Amyloid-β 1–40 in a Prospective Dyslipidemia Cohort
Background Circulating amyloid β 1–40 (Aβ40), a pro-inflammatory and pro-atherogenic peptide, is an emerging biomarker in atherosclerotic cardiovascular disease (ASCVD), but evidence on its modulation by cardiovascular therapies is limited and conflicting. We explored associations between statin therapy and Aβ40 plasma...